PSA
30
-5
HES
79
2
HCA
35
-9
XYL
60
4
ADP
58
-4
AKAM
45
2
HCP
78
-2
VNO
60
-3
WM
85
-3
UHS
62
-2
AIZ
66
-2
CMG
72
-2
SRE
52
2
PXD
48
-6
AON
23
-9
CL
64
3
CTAS
55
2
EXR
35
2
C
46
2
VTR
78
2
PSA
30
-5
HES
79
2
HCA
35
-9
XYL
60
4
ADP
58
-4
AKAM
45
2
HCP
78
-2
VNO
60
-3
WM
85
-3
UHS
62
-2
AIZ
66
-2
CMG
72
-2
SRE
52
2
PXD
48
-6
AON
23
-9
CL
64
3
CTAS
55
2
EXR
35
2
C
46
2
VTR
78
2
Financhill
Back

Paramount Group 10K Form

Buy
65

PGRE
Paramount Group

Last Price:
4.67
Seasonality Move:
-3.29%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive PGRE News And Ratings

See the #1 stock for the next 7 days that we like better than PGRE

PGRE Financial Statistics

Sales & Book Value

Annual Sales: $742.79M
Cash Flow: $102.26M
Price / Cash Flow: 3.65
Annual Sales: $14.74
Price / Book: 0.32

Profitability

EPS (TTM): -1.20000
Net Income (TTM): $-259.74M
Gross Margin: $448.82M
Return on Equity: -6.04%
Return on Assets: -3.12%

Paramount Group Earnings Forecast

Key Paramount Group Financial Ratios

  • The Gross Profit Margin over the past 13 years for PGRE is 60.42%.
  • The Selling, General & Administrative Expenses for PGRE have been equal to 8.35% of Gross Profit Margin.
  • The Research & Development expenses have been 0.00% of Revenue.
  • The Interest Expense is -56.51% of Operating Income.
  • The Net Earning history of PGRE is -34.97% of Total Revenues.
  • Per Share Earnings over the last 13 years have been positive in 5 years.

Paramount Group Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Office REITs
Sector: Real Estate
Current Symbol: PGRE
CUSIP: 69924R
Website: pgre.com

Debt

Debt-to-Equity Ratio: 1.19
Current Ratio: 7.16
Quick Ratio: 6.49

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

PGRE Technical Analysis vs Fundamental Analysis

Buy
65
Paramount Group (PGRE) is a Buy

Is Paramount Group a Buy or a Sell?

  • Paramount Group stock is rated a Buy
    The current Paramount Group [PGRE] share price is $4.67. The Score for PGRE is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.